Phase I clinical and pharmacokinetic study of orally administeredN4-palmitoyl-1-β-d-arabinofuranosylcytosine

R. Ohno,K. Kimura,K. Ota,Y. Miura,A. Hoshino,K. Hattori,M. Hirano,Munemoto Ito,T. Maekawa,Toru Nakamura,I. Kimura,M. Ichimaru,Y. Uzuka,M. Oguro,T. Miyazaki
DOI: https://doi.org/10.1007/BF02934942
1987-06-01
Medical Oncology and Tumor Pharmacotherapy
Abstract:
What problem does this paper attempt to address?